Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von MedCity News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrPfizer's First Gene Therapy Approval Sets Up a Showdown With CSL in Hemophilia B
FrRevolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
FrStartUPDATES: New Developments from Healthcare Startups
FrHow Will Walgreens' Expansion into Specialty Pharmacy Affect the Industry?
DoWhich AI Applications Interest Your Employer Clients the Most? Where Will They Have the Greatest Impact?
DoDebunking the Myths Around Patient Financing
DoRegeneron Bets $100M That Mammoth's CRISPR Tech Can Deliver on Next Wave of Genetic Medicines
DoExamining the Usefulness of the Lean Startup Method in Building Health Tech Products
DoWith All the Organ Donation Scrutiny, Ask: What Can We Do to Reduce the Need?
DoProvidence Ordered to Pay $200M for 'Systemic Wage Violations'
DoFDA Drug Approval Marks a New Day for Treating Pediatric Brain Cancer
MiIt's Time to Give Patients a Seat at the Table
MiTo Further Impede the Progression of Heart Disease, We Must Treat Patients With Anti-Inflammatory Drugs in Combination With Statin Therapy
MiFTC Chief Says Tech Advancements Risk Healthcare Price Fixing
MiSix Biopharma Companies to Watch at MedCity INVEST Pitch Perfect Contest
MiWhen Investment Rhymes with Canada
MiPatient Engagement Is Essential for Achieving the Goals of Value-Based Care
MiWhy Headspace Is Launching Direct-to-Consumer Services
DiFDA Approves Immunotherapy That Can Spare Bladder Cancer Patients From Radical Surgery
DiDon't Let Inflation Bloat Your Drug Spending
DiCollaboration Now: Maximizing AI's Potential in the Industry it Matters Most
DiNeurodivergent Masking: A Hidden Contributor to the $2-Trillion Burnout Crisis
DiTakeda, Astellas & Sumitomo Mitsui Form Joint Venture to Lift Japanese Innovation From 'Valley of Death'
MoHospital Discharge Backlogs Impacting Patient Outcomes
MoDelivering the Right Approach for Virtual Primary Care: 3 Key Insights